‘Big science’ spurs collaborative trend
Complicated projects mean that science is becoming more globalized.
NIH scrutinizes drug-company payments at Baylor
Funding agency raises ‘serious concerns’ about conflicts of interest.
GlaxoSmithKline goes public with malaria data
Company to place structures and properties of drug leads in the public domain.